Latest News about BIIB
Recent news which mentions BIIB
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
3 Biotech Stocks to Watch for Potential Breakthroughs
April 11, 2023
From InvestorPlace
From Benzinga
Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
April 11, 2023
From Benzinga
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
From InvestorPlace
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
From Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Tickers
BIIB
From Benzinga
Tickers
BIIB
From MarketWatch
From InvestorPlace
Wall Street predicts approval for another ALS drug
March 21, 2023
From MarketWatch
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Tickers
BIIB
From Benzinga
From Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
